Pyc Therapeutics Ltd has released a press release.
Sept 2018 Quarterly Operations Update and App4C
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Story so far
Earlier from PYC Therapeutics
- Fourfold Delivery Improvement in a New Lead Candidate
- R&D Tax Incentive Refund
- Reinstatement to Official Quotation
- Phylogica Recapitalisation
- Suspension from Official Quotation
Later from PYC Therapeutics
- AGM Company Presentation
- FNA Presentation
- Successful Delivery of CRIPR/Cas9 into Cells ex vivo
- In vivo success - peptide vaccine in Herpes Simplex Virus
- In Vivo Success - peptide vaccine (Amended Graphics)
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics